- Home
- News & Events
- Events
- Webinars
Webinars
-
Webinars
Webinar: Risk Based Monitoring - The Site Perspective
Date 13 September 2018 Time 14:00 - 15:00 Location Webinar Timezone Europe/London -
Webinars
Industry Perceptions and Expectations
Date 31 July 2018 Time 11:00 - 12:00 Location Webinar Timezone America/New York Who has the job of leading the evaluation of pharmaceutical value and pricing? What impact will ICER have on payer decision-making? Will manufacturers begin to adjust their list prices to reflect valuations made in ICER reports? These questions and more continue to be at the heart of discussions surrounding how to gauge value in the US healthcare system.
As manufacturers begin to be more proactive in preparation for ICER evaluations, earlier monitoring of updates to ICER value frameworks and consideration of competitor and analog ICER assessments should be a priority, particularly in relation to the development of economic models, pricing strategies, and contracting approaches. Gathering of proactive scientific advice from ICER influencers and stakeholders will better prepare manufacturers for the inevitable challenges that stem from a negative ICER assessment. Incorporation of ICER guidelines, similar to other tactics like the development of an AMCP dossier, should be considered as early as possible when developing market access strategies. Only time will tell if ICER becomes the next NICE—but for now, it is a force that is here to stay and to be reckoned with.
This webinar will explore:
- The evolution of health technology assessment in the US and possibilities for the future
- Opinions of manufacturers and US payer stakeholders on the role of ICER in the US healthcare system, as learned through a primary research study of more than 50 participants
- ICER methodologies and approaches to evaluation of clinical and health economic evidence
- Ways manufacturers can begin to more proactively prepare for an ICER assessment
-
Webinars
Impact of FDA’s Recent Guidance on Payer Communications
Date 23 July 2018 Time 10:00 - 11:00 Location Webinar Timezone America/New York -
Webinars
Non-Alcoholic Steatohepatitis (NASH) Clinical Trials
Date 17 July 2018 Time 11:00 - 12:00 Location Webinar Timezone America/New York Join Andrew Roche, PhD, a senior member of ICON's NASH team, as he speaks about overcoming the challenges and considerations associated with NASH Clinical Trials and examination of potential strategies to address during trial design or study execution.
-
Webinars
A Strategic Technology Driven Approach
Date 24 May 2018 Time 10:00 - 11:00 Location Webinar Timezone America/Bogota -
Webinars
The Rare Disease Revolution
Date 25 January 2018 Time 16:00 - 17:00 Location Webinar Timezone Europe/London New regulatory developments in both the US and Europe are promoting a radical change to accelerate the approval of new medications for rare disease. These include the 21st Century Cure Act in the US and the Adaptive Regulatory Pathway in Europe.
-
Webinars
eConsent
Date 7 December 2017 Time 14:00 - 15:00 Location Webinar Timezone Europe/London This webinar recording explores the latest industry and regulatory developments relating to the use of eConsent in clinical trials and what sponsors and sites need to consider before they deploy this in clinical trials.
-
Webinars
Real World Evidence Across the Product Lifecycle
Date 17 November 2017 Time 11:00 - 12:00 Location Webinar Timezone America/New York This webinar will discuss how real world evidence is playing a larger role across the entire product life cycle, with a focus on late phase regulatory discussions and payer decision-making.
-
Webinars
What's Next in eCOA?
Date 16 November 2017 Time 16:00 - 17:00 Location Webinar Timezone Europe/London
ICON’s Webinar Channel
A library of recorded webinars exploring topics ranging from early to late phase.